CVAid focuses on the field of stroke telemedicine (telestroke), aiming to improve stroke diagnosis and spread its advanced technologies to save lives. The company offers a full-cycle stroke diagnosis and disease management platform, encompassing pre-hospital early diagnosis, in-hospital process management, and follow-up upon discharge from the hospital. The company's CVA-Flow is a comprehensive telestroke system that ensures early and accurate diagnosis of stroke by certified neurology teams using a standard smartphone and dedicated cloud servers. The CVA-Flow, supported by its artificial-intelligence module (CVA-Core), synchronizes all stroke stakeholders (e.g. patients, EMS, ER, stroke centers, medical teams, and management). CVAid uses a proprietary database of visual and auditory recordings of stroke patients, along with machine- and deep-learning tools, to create an all-in-one software solution that analyzes data in real time, providing neurologists with support tools to remotely diagnose patients without sacrificing quality.